Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Salt'n'Peppa who wrote (7899)	10/26/2001 8:24:38 PM
From: Montana Wildhack	Read Replies (1) \| Respond to of 14101

S&P, CG, Nice work guys bringing related information to the table. Last month, staff reviewers for the U.S. Food and Drug Administration recommended against approval of IntraDose because of concerns the therapy had shown limited effectiveness and moderate to severe toxicity. Pennsaid won't be facing that verdict. I'll spend some time looking on the weekend. I'd like to know if possible when they submitted to the FDA and when phase III results were completed. Wolf